QUOTE
Eli Lilly and Company (LLY)
$
39.44
 -0.45 (-1.13%) Jan 26
|
Lilly Corporate Center
,
Indianapolis,
IN
46285
,
USA
+1-317-276-2000
http://www.lilly.com |
|
|
| PRICES |
| Open |
Volume |
| 39.91 |
8.69M |
| High |
Low |
| 40.02 |
39.34 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 45446 |
2.57M |
| 52wk High |
52wk Low |
| 41.80 |
33.63 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| 10.78 |
3.66 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| 1.96 |
4.97% |
| Shares |
Inst Owner |
| 1152.29 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2007 | 2008 | 2009 | 2010 |
| Income statement |
| Total Revenue |
$18,633.50 | $20,378 | $21,836 | $23,076 |
| Operating Income |
$3,876.80 | $-1,307.60 | $5,357.80 | $6,525.20 |
| Net Income |
$2,953 | $-2,071.90 | $4,328.80 | $5,069.50 |
| Balance Sheet |
| Total Assets |
$26,874.80 | $29,212.60 | $27,460.90 | $31,001.40 |
| Total Equity |
$13,503.90 | $6,735.30 | $9,523.70 | $12,420.30 |
| Total Liabilities |
$13,370.90 | $22,477.30 | $17,937.20 | $18,581.10 |
| Cash Flow |
| Operating |
$5,154.50 | $7,295.60 | $4,335.50 | $6,856.80 |
| Investing |
$-4,328.10 | $-7,268.80 | $142.80 | $-3,159.80 |
| Financing |
$-844.90 | $2,346 | $-5,533.70 | $-2,021.90 |
| Net Cash Change |
$111.20 | $2,276.20 | $-1,033.80 | $1,530.30 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
28 January 2010
19 April 2010
22 July 2010
21 October 2010
|
29 January 2009
20 April 2009
22 July 2009
21 October 2009
|
29 January 2008
21 April 2008
24 July 2008
23 October 2008
|
31 January 2007
16 April 2007
24 July 2007
18 October 2007
|
26 January 2006
20 April 2006
21 July 2006
19 October 2006
| |
|
| Earning Call Summary |
Transcripts |
| |
|
Management
|
|
Executive |
Title |
|
Sidney Taurel |
Chairman of the Board, Chief Executive Officer | |
|
Lorenzo Tallarigo |
President - International Operations |
|
Frank Deane |
President of Manufacturing |
|
Deirdre P. Connelly |
President - U.S. Operations |
|
John C. Lechleiter |
President, Chief Operating Officer, Director |
|
Derica W. Rice |
Chief Financial Officer, Senior Vice President |
|
Steven M. Paul |
Executive Vice President for Science and Technology; President - Lilly Research Laboratories |
|
Robert A. Armitage |
Senior Vice President, General Counsel |
|
Anthony J. Murphy |
Senior Vice President - Human Resources |
|
Alex M. Azar |
Senior Vice President - Corporate Affairs and Communications |
|
|
|
